A50 — Thomson Medical Income Statement
0.000.00%
Last trade - 00:00
- SG$1.32bn
- SG$2.25bn
- SG$355.77m
- 20
- 24
- 62
- 23
2018 December 31st | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 18 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 216 | 328 | 240 | 334 | 356 |
Cost of Revenue | |||||
Gross Profit | 171 | 258 | 191 | 278 | 296 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 178 | 373 | 192 | 242 | 274 |
Operating Profit | 37.2 | -45.4 | 48.8 | 91.8 | 82.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 22 | -79.5 | 26.2 | 69.3 | 55.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 14.7 | -93.9 | 16.9 | 58.6 | 41.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2.16 | -99.2 | 14.2 | 53.8 | 36.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.16 | -99.2 | 14.2 | 53.8 | 36.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0 | -0.001 | 0.001 | 0.002 | 0.001 |
Dividends per Share |